Transfusion Medicine is the proceedings of the 25th Jubilee International Symposium on Blood Transfusion and reviews what has been achieved and what can be expected. There have been many achievements during the last quarter of the 20th century - for example the Landsteiner discovery of red cell markers and the Huestin development of an appropriate anticoagulant. The proceedings of this landmark symposium offer a wealth of information on the future of this new and evolving field of medicine. The material is presented in four sections: Blood Supply Systems and Organisation; Technical and Pharmaceutical Developments; Quality Principles and Risk Management; and Transfusion Medicine for the Patient. Transfusion Medicine provides a comprehensive review of this area and its accomplishments and future directions. This is a worthwhile and recommended edition for those involved in transfusion medicine: clinicians, policy makers, and researchers.
Transfusion Medicine is the proceedings of the 25th Jubilee International Symposium on Blood Transfusion and reviews what has been achieved and what can be expected. There have been many achievements during the last quarter of the 20th century - for example the Landsteiner discovery of red cell markers and the Huestin development of an appropriate anticoagulant. The proceedings of this landmark symposium offer a wealth of information on the future of this new and evolving field of medicine. The material is presented in four sections: Blood Supply Systems and Organisation; Technical and Pharmaceutical Developments; Quality Principles and Risk Management; and Transfusion Medicine for the Patient. Transfusion Medicine provides a comprehensive review of this area and its accomplishments and future directions. This is a worthwhile and recommended edition for those involved in transfusion medicine: clinicians, policy makers, and researchers.
Daugiau informacijos
Springer Book Archives
Moderators and Speakers xi Foreword xiii I. BLOOD SUPPLY SYSTEMS AND ORGANISATION Blood Transfusion: Quo Vadis? Customer Orientation as the Leading Principal for Blood Banks in the Future 3(18) Th.E.P. Lotgerink Community Involvement: The Development, the Past -- the Present and the Future of Blood Donations as a Form of Community Involvement 21(10) A.P.M. Los Structure and Commitments -- Blood Supply Systems and Organization 31(6) J.C. Emmanuel Applying Decision Analysis to Transfusion Medicine in the Real World to Improve Transfusion Safety 37(8) J.P. AuBuchon Cost-Effectiveness of HIV NAT Screening for Dutch Donors 45(8) M.J. Postma Legal and Regulatory Aspects of Blood Transfusion 53(16) M.L. Kavanagh Discussion 57(12) II. TECHNICAL AND PHARMACEUTICAL DEVELOPMENTS Freezing and Vitrification of Red Cells, Recollections and Predictions 69(18) H.T. Meryman Plasma Fractionation 87(16) P.R. Foster Viral Marker Screening: Is More Testing Safer? 103(10) J-P. Allain Inactivation of Viruses, Bacteria, Protozoa, and Leukocytes in Labile Blood Components by Using Nucleic Acid Targeted Methods 113(12) L.M. Corash Alternatives to Human Blood Resources 125(22) P.M. Ness Discussion 133(14) III. QUALITY PRINCIPLES AND RISK MANAGEMENT Quality Systems and Management: 2000 Where Have We Been and Where Are We Going? 147(14) K. Sazama Traceability and Coding Principles 161(12) J. Koistinen Quality Principles and Risk Management: Automation and Documentation 173(16) M. Bruce Haemovigilance 189(12) N. Drouet Human Resources: Teaching and Training in Transfusion Medicine 201(18) J.F. Harrison Discussion 209(10) IV. TRANSFUSION MEDICINE AT THE BESIDE The Epidemiology of Blood Component Transfusion in South Eastern Scotland, 1990 to 1997 219(10) D.B.L. McClelland Contributions of Meta-Analysis to Transfusion Medicine 229(22) E.C. Vamvakas Immunomodulation: Facts and Interpretations 251(12) A. Brand Development and Implementation of New Cellular Therapies 263(10) J. McCullough Transfusion Medicine and the Development of Gene Therapy 273(8) M.L. Turner Making Policy in the 2000s 281(14) J.C. Emmanuel Discussion 285(10) Index 295
